Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-Intensity Interval Training (HIT) for Breast Cancer Patients During Trastuzumab Use

NCT02454777 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT02454777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02454777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-Intensity Interval Training (HIT) for Breast Cancer Patients During Trastuzumab Use
Lead sponsor
University of Southern California
Phase
Not applicable
Overall status
Terminated
Start date
September 29, 2015
Completion date
July 15, 2019
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage ia breast cancer, stage ib breast cancer, stage iia breast cancer, stage iib breast cancer, stage iiia breast cancer, stage iiib breast cancer, stage iiic breast cancer